Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support
Leonard, J.P.
Current Hematology Reports 2(6): 451-452
2003
ISSN/ISBN: 1540-3408 PMID: 14561387 Document Number: 562213
Document emailed within 1 workday
Related Documents
Kizawa, R.; Ozaki, Y.; Kondoh, C.; Tanabe, Y.; Takano, T. 2017: I. Dose-Dense Chemotherapy as Perioperative Treatment in Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(13): 2073-2076Burtness, B.; Windsor, S.; Holston, B.; DiStasio, S.; Staugaard-Hahn, C.; Abrantes, J.; Kneuper-Hall, R.; Farber, L.; Orell, J.; Bober-Sorcinelli, K.; Haffty, B.G.; Reiss, M. 1999: Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting Cancer Journal From Scientific American 5(4): 224-229
Senn, H.J. 1985: Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 91: 421-428
Blohmer, J.U.; Paepke, S.; Kissner, L.; Elling, D.; Fleige, B.; Grineisen, Y.; Lichtenegger, W. 1999: Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission Zentralblatt für Gynakologie 121(11): 522-525
Meropol, N.J.; Overmoyer, B.A.; Stadtmauer, E.A. 1992: High-dose chemotherapy with autologous stem cell support for breast cancer Oncology 6(12): 53-60; 63; Discussion: 63-4 69
Liu, L.; Liu, Z-zhe.; Liu, Y-ye.; Zheng, Z-dong.; Liang, X-feng.; Han, Y-ling.; Xie, X-dong. 2013: Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 35(12): 936-940
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250
Melichar, B.; Urbánek, L.; Krcmová, L.; Kalábová, H.; Melicharová, K.; Malírová, E.; Hornychová, H.; Ryska, A.; Hyspler, R.ír.; Solichová, D. 2008: Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy Anticancer Research 28(4c): 2389-2396
1995: Growth factor allows effective dose-intensive regimen in advanced breast cancer patients Oncology 9(7): 684
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597
Murayama, Y.; Mishima, Y. 1988: Effect of transforming growth factor-beta and epidermal growth factor on cell growth of human breast cancer Nihon Geka Gakkai Zasshi 89(2): 312
Seidman, A.D.; Hudis, C.A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M.E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L. 1997: Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Evans, R.A. 1995: Adjuvant chemotherapy in breast cancer New England Journal of Medicine 333(9): 596-597
Kennedy, B.J. 1979: Adjuvant chemotherapy of breast cancer Minnesota Medicine 62(7): 509-511
Semiglazov, V.F.; Golubeva, O.M.; Bavli, I.L.; Ivanova, O.A.; Topuzov, E.E. 1992: The adjuvant chemotherapy of breast cancer Voprosy Onkologii 38(10): 1187-1194
Singhal, N.; Bapsy, P.P. 2003: Breast cancer and adjuvant chemotherapy National Medical Journal of India 16(4): 214-215